Related Experiment Videos
Nuclear BMI-1 expression in laryngeal carcinoma correlates with lymph node pathological status
Eugenia Allegra1, Lidia Puzzo, Valeria Zuccalà
1Department of Otolaryngology-Head and Neck Surgery, University of Catanzaro, Catanzaro, Italy. eualle@unicz.it
World Journal of Surgical Oncology
|October 4, 2012
Summary
High nuclear expression of B cell-specific Moloney murine leukemia virus integration site 1 (BMI-1) in laryngeal cancer predicts lymph node metastasis. This finding may improve staging for laryngeal squamous cell carcinoma patients.
Area of Science:
- Oncology
- Molecular Pathology
Background:
- Laryngeal squamous cell carcinoma (LSCC) metastasis to regional lymph nodes is a primary cause of treatment failure and mortality.
- Current staging methods struggle to identify patients with occult metastasis.
- Discovering novel molecular markers is crucial for understanding LSCC pathogenesis and improving clinical management.
Purpose of the Study:
- To investigate the expression of B cell-specific Moloney murine leukemia virus integration site 1 (BMI-1) in LSCC.
- To determine if BMI-1 expression correlates with lymph node metastasis in LSCC patients.
Main Methods:
- Immunohistochemical analysis of BMI-1 expression in primary LSCC tissue specimens from 64 untreated patients.
- Correlation analysis between BMI-1 expression levels (nuclear and cytoplasmic) and clinicopathological factors, including lymph node metastasis.
Main Results:
- Nuclear BMI-1 (nBMI-1) expression was observed in 50% of LSCC tumors, with high expression levels in 87.5% of positive cases.
- Cytoplasmic BMI-1 (cBMI-1) was detected in 34.4% of tumors.
- Multivariate analysis identified high nBMI-1 expression as an independent prognostic factor for lymph node metastasis in LSCC.
Conclusions:
- BMI-1 expression, particularly nuclear localization, is significantly associated with lymph node metastasis in laryngeal carcinoma.
- nBMI-1 may serve as a valuable biomarker for predicting metastatic potential in LSCC, aiding in risk stratification and treatment decisions.
Related Concept Videos
02:39lncRNA - Long Non-coding RNAs
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
02:55The Nucleolus
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...